ABN Amro Boosts Stake in Merck & Co., Inc.
ABN Amro Investment Solutions has increased its stake in Merck & Co., Inc. (NYSE:MRK), purchasing an additional 75,355 shares in the second quarter.
The institutional investor now owns 309,009 shares of the company's stock, valued at $39,708,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
This represents a 32.3% increase in ABN Amro Investment Solutions' holdings in Merck & Co., Inc.
Merck & Co., Inc. recently declared a quarterly dividend, which will be paid on Wednesday, October 7th. Stockholders of record on Tuesday, September 15th will receive a $0.85 dividend, representing an annualized rate of $3.40 and a dividend yield of 2.5%.
The company's dividend payout ratio (DPR) is currently 272.00%, which some may see as high but is within the context of the industry standard.